Square Pharmaceuticals PLC. (DSE: SQURPHARMA)
Health Care · Pharmaceuticals · BD
Tk218.80
-0.18% today · -1.3% 1Y
Square Pharmaceuticals PLC. (DSE: SQURPHARMA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.59B.
Over the last twelve months the share price has lost 1.3%, trading between 198.00 and 236.00.
Tweenvest scores Square Pharmaceuticals PLC. across four factors: quality 90/100, value 88/100, growth 35/100, dividend 98/100. Its strongest factor is dividend.
SQURPHARMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.59B
- Revenue (TTM)
- $681.13M
- P/E
- 7.50
- EPS
- 29.18
- Dividend yield
- 5.48%
- Beta (5Y)
- 0.09
- 52-week high
- Tk236.00
- 52-week low
- Tk198.00
- Avg volume (3M)
- —
- Shares outstanding
- 886.45M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,234.81 | +0.09% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.37 | +0.08% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.00 | -0.29% |
| Roche Holding AGSWX: ROP | $371.62B | CHF370.90 | -0.78% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.18 | -1.27% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.